Screening techniques for drug discovery in Alzheimer's disease

QR Code

Screening techniques for drug discovery in Alzheimer's disease

Alzheimer’s disease (AD) is a neurodegenerative disorder characterized by progressive and irreversible impairment of memory and other cognitive functions of the aging brain. Pathways such as amyloid beta neurotoxicity, tau pathogenesis and neuroinflammatory have been used to understand AD, despite n...

Full description

Bibliographic Details
Main Authors:	Maniam, Sandra, Maniam, Subashani
Format:	Article
Language:	English
Published:	American Chemical Society 2024
Online Access:	http://psasir.upm.edu.my/id/eprint/117608/ http://psasir.upm.edu.my/id/eprint/117608/1/117608.pdf

Similar Items

Phytochemical screening expedition 2009 : drug discovery from nature.
by: Mat So'ad, Siti Zaiton, et al.
Published: (2011)

Hypoxia-induced neuroinflammation in Alzheimer’s disease: potential neuroprotective effects of Centella asiatica
by: Hambali, Aqilah, et al.
Published: (2021)

Alzheimer's disease talk
by: The Star,
Published: (2012)

Diet and Alzheimer's disease
by: Creegan, R., et al.
Published: (2013)

Models of Alzheimer’s Disease
by: Chen, M., et al.
Published: (2014)

The use of cell culture technique in small molecule antidiabetes drug discovery
by: Bakhtiar, M. Taher
Published: (2019)

The role of endocannabinoids in Alzheimer's disease
by: Maroof, Nazia
Published: (2013)

Animal Models of Alzheimer's Disease
by: Newman, M., et al.
Published: (2017)

Molecular Genetics of Alzheimer's Disease
by: Verdile, Giuseppe, et al.
Published: (2009)

Consumption of fish and Alzheimer's Disease
by: Newton, Wendy, et al.
Published: (2011)

Multitarget drug design strategy in Alzheimer’s disease: focus on cholinergic transmission and amyloid-β aggregation
by: Simioni, Elena, et al.
Published: (2017)

Open source drug discovery with the Malaria Box Compound collection for neglected diseases and beyond
by: Phillips, Margaret A., et al.
Published: (2016)

Developing Science Gateways for Drug Discovery in a Grid Environment
by: Pérez‑Sánchez, Horacio, et al.
Published: (2016)

The importance of in-silico studies in drug discovery
by: Roney, Miah, et al.
Published: (2024)

Kinase targets in CNS drug discovery
by: Gunosewoyo, Hendra, et al.
Published: (2017)

The evolutionary development in drug discovery and delivery
by: Ithnin, Hairuszah, et al.
Published: (2013)

Screening exons 16 and 17 of the amyloid precursor protein gene in sporadic early-onset Alzheimer’s disease
by: Barber, Imelda S., et al.
Published: (2016)

Screening exon 16 and 17 of the amyloid precursor protein gene in sporadic early-onset Alzheimer's disease
by: Barber, Imelda S., et al.
Published: (2016)

Repurposing of dipeptidyl peptidase FDA-approved drugs in Alzheimer's disease using network pharmacology and in-silico approaches
by: Roney, Miah, et al.
Published: (2025)

Investigating genetic variation in Alzheimer’s disease
by: Patel, Tulsi
Published: (2018)

The Role of Luteinizing Hormone in Alzheimer’s Disease
by: Barron, A., et al.
Published: (2010)

Screen design with dynamic symmetry: A discovery
by: Ngo,, DCL, et al.
Published: (2005)

Changes in Brain Transcripts Related to Alzheimer’s Disease in a Model of HFE Hemochromatosis are not Consistent with Increased Alzheimer’s Disease Risk
by: Johnstone, D., et al.
Published: (2012)

Investigating polygenic risk scores in Alzheimer's disease
by: Chaudhury, Sultan Raja
Published: (2024)

Genetic underpinnings in Alzheimer’s disease – A review
by: Moustafa, Ahmed A., et al.
Published: (2017)

Investigation into patterns of epigenetic regulation of Alzheimer’s disease
by: Boden, Kirsty
Published: (2019)

Memory, ageing and Alzheimer's disease: the case for Malaysia
by: Dzulkifli, Mariam Adawiah
Published: (2012)

Anatomical analysis of brain MRI in Alzheimer’s disease
by: Farzan, Ali, et al.
Published: (2014)

Alzheimer's disease: undiagnosed due to lack of awareness
by: Roslan, Muhammad Basir
Published: (2020)

The genetics of Alzheimer's disease: putting flesh on the bones
by: Medway, C., et al.
Published: (2014)

Postural Stability in Older Adults With Alzheimer Disease
by: Mesbah, N., et al.
Published: (2017)

Chylomicron amyloi-beta in the aetiology of Alzheimer's disease
by: Takechi, Ryu, et al.
Published: (2008)

Cholesterol metabolism and transport in the pathogenesis of Alzheimer's disease
by: Martins, I.j, et al.
Published: (2009)

Zebrafish as a tool in Alzheimer's disease research
by: Newman, M., et al.
Published: (2011)

Yeast as a model for studying Alzheimer's disease
by: Bharadwaj, Prashant, et al.
Published: (2010)

Computer-aided anti-cancer drug discovery of EGFR protein based on virtual screening of drug bank, ADMET, docking, DFT and molecular dynamic simulation studies
by: Roney, Miah, et al.
Published: (2023)

AI-Based Drug Design: Revolutionizing Drug Discovery through in Silico Analysis
by: Yamini Priya, Deepthimahanthi, et al.
Published: (2023)

The Link Between Diabetes, Glucose Control, and Alzheimer's Disease and Neurodegenerative Diseases
by: Verdile, Giuseppe, et al.
Published: (2019)

A practical drug discovery project at the undergraduate level
by: Fray, Michael J., et al.
Published: (2013)

The structural modification of natural products for novel drug discovery
by: Yao, Hong, et al.
Published: (2016)